SCHEMBL29529285

SCHEMBL29529285

Cc1ccc(NC(=O)N2CCC(C(C)(C)S(=O)(=O)c3cccc(F)c3)CC2)cn1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.51
CYP3A4 P08684 2/20 0.49
NR1I2 O75469 1/20 0.49
CACNA1B Q00975 1/20 0.49
KMT2A Q03164 3/20 0.47
CSNK1E P49674 1/20 0.47
NPC1 O15118 2/20 0.45
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
NAMPT P43490 1/20 0.41
HPGDS O60760 1/20 0.41
OPRM1 P35372 1/20 0.41
CYP2D6 P10635 1/20 0.41
ALDH1A1 P00352 2/20 0.41
USP2 O75604 1/20 0.41
CYP2C9 P11712 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17949163 1.00 TSHR (0.51) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL29529596 0.93 TSHR (0.47) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL17949479 0.93 TSHR (0.47) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL17949146 0.92 TSHR (0.52) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL29529779 0.92 TSHR (0.52) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL17949041 0.91 TSHR (0.52) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL29530465 0.90 TSHR (0.50) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL17949035 0.90 TSHR (0.50) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL17949154 0.88 TSHR (0.49) TSHRCYP3A4NR1I2CACNA1BKMT2A
SCHEMBL29529704 0.88 TSHR (0.49) TSHRCYP3A4NR1I2CACNA1BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MYOKARDIA INC (US) 2025-09-04 US disclosed
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MyoKardia, Inc. 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 TSHR 3993/4885CYP3A4 4065/4885NR1I2 1440/4885
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 TSHR 3993/4885CYP3A4 4065/4885NR1I2 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.